MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAF(V600E) Mutation Detected in Circulating-Free DNA

por Salemi, Rossella, Falzone, Luca, Madonna, Gabriele, Polesel, Jerry, Cinà, Diana, Mallardo, Domenico, Ascierto, Paolo A., Libra, Massimo, Candido, Saverio
Publicado 2018

Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab

por Morello, Silvana, Capone, Mariaelena, Sorrentino, Claudia, Giannarelli, Diana, Madonna, Gabriele, Mallardo, Domenico, Grimaldi, Antonio M., Pinto, Aldo, Ascierto, Paolo Antonio
Publicado 2017

Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients

por Tallerico, Rossana, Cristiani, Costanza M, Capone, Mariaelena, Madonna, Gabriele, Mallardo, Domenico, Simeone, Ester, Dominijanni, Andrea, Grimaldi, Antonio M, Colucci, Francesco, Ascierto, Paolo A, Carbone, Ennio
Publicado 2015

Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations

por Ascierto, Paolo A., Capone, Mariaelena, Grimaldi, Antonio M., Mallardo, Domenico, Simeone, Ester, Madonna, Gabriele, Roder, Heinrich, Meyer, Krista, Asmellash, Senait, Oliveira, Carlos, Roder, Joanna, Grigorieva, Julia
Publicado 2019

The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies

por Maraolo, Alberto Enrico, Crispo, Anna, Piezzo, Michela, Di Gennaro, Piergiacomo, Vitale, Maria Grazia, Mallardo, Domenico, Ametrano, Luigi, Celentano, Egidio, Cuomo, Arturo, Ascierto, Paolo A., Cascella, Marco
Publicado 2021

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

por Capone, Mariaelena, Giannarelli, Diana, Mallardo, Domenico, Madonna, Gabriele, Festino, Lucia, Grimaldi, Antonio Maria, Vanella, Vito, Simeone, Ester, Paone, Miriam, Palmieri, Giuseppe, Cavalcanti, Ernesta, Caracò, Corrado, Ascierto, Paolo Antonio
Publicado 2018

ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Aut...

por Ruggiero, Ciro Francesco, Malpicci, Debora, Fattore, Luigi, Madonna, Gabriele, Vanella, Vito, Mallardo, Domenico, Liguoro, Domenico, Salvati, Valentina, Capone, Mariaelena, Bedogni, Barbara, Ascierto, Paolo Antonio, Mancini, Rita, Ciliberto, Gennaro
Publicado 2019

Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors

por Cristiani, Costanza Maria, Capone, Mariaelena, Garofalo, Cinzia, Madonna, Gabriele, Mallardo, Domenico, Tuffanelli, Marilena, Vanella, Vito, Greco, Marta, Foti, Daniela Patrizia, Viglietto, Giuseppe, Ascierto, Paolo Antonio, Spits, Hergen, Carbone, Ennio
Publicado 2022

Potential clinical implications of CD4(+)CD26(high) T cells for nivolumab treated melanoma patients

por Galati, Domenico, Zanotta, Serena, Capone, Mariaelena, Madonna, Gabriele, Mallardo, Domenico, Romanelli, Marilena, Simeone, Ester, Festino, Lucia, Sparano, Francesca, Azzaro, Rosa, De Filippi, Rosaria, Pinto, Antonio, Paulos, Chrystal M., Ascierto, Paolo A.
Publicado 2023

PD-L1(+) neutrophils as novel biomarkers for stage IV melanoma patients treated with nivolumab

por Cristinziano, Leonardo, Modestino, Luca, Capone, Mariaelena, Madonna, Gabriele, Mallardo, Domenico, Giannarelli, Diana, D’Angelo, Grazia, Ferrara, Anne Lise, Loffredo, Stefania, Varricchi, Gilda, Vanella, Vito, Festino, Lucia, Ascierto, Paolo Antonio, Galdiero, Maria Rosaria
Publicado 2022

The Ratio of GrzB(+) − FoxP3(+) over CD3(+) T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic Melanoma

por Scognamiglio, Giosuè, Capone, Mariaelena, Sabbatino, Francesco, Di Mauro, Annabella, Cantile, Monica, Cerrone, Margherita, Madonna, Gabriele, Grimaldi, Antonio Maria, Mallardo, Domenico, Palla, Marco, Sarno, Sabrina, Anniciello, Anna Maria, Di Bonito, Maurizio, Ascierto, Paolo Antonio, Botti, Gerardo
Publicado 2021

CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy

por Mallardo, Domenico, Fordellone, Mario, White, Andrew, Ottaviano, Margaret, Sparano, Francesca, Bailey, Michael, Facchini, Arianna Bianca, Ong, Sufey, Maiolino, Piera, Caracò, Corrado, Church, Sarah, Cavalcanti, Ernesta, Warren, Sarah, Budillon, Alfredo, Cesano, Alessandra, Simeone, Ester, Chiodini, Paolo, Ascierto, Paolo Antonio
Publicado 2023

Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma

por Fattore, Luigi, Ruggiero, Ciro Francesco, Pisanu, Maria Elena, Liguoro, Domenico, Cerri, Andrea, Costantini, Susan, Capone, Francesca, Acunzo, Mario, Romano, Giulia, Nigita, Giovanni, Mallardo, Domenico, Ragone, Concetta, Carriero, Maria Vincenza, Budillon, Alfredo, Botti, Gerardo, Ascierto, Paolo Antonio, Mancini, Rita, Ciliberto, Gennaro
Publicado 2018

A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation

por Simeone, Ester, Scognamiglio, Giosuè, Capone, Mariaelena, Giannarelli, Diana, Grimaldi, Antonio M., Mallardo, Domenico, Madonna, Gabriele, Curvietto, Marcello, Esposito, Assunta, Sandomenico, Fabio, Sabbatino, Francesco, Bayless, Nicholas L., Warren, Sarah, Ong, SuFey, Botti, Gerardo, Flaherty, Keith T., Ferrone, Soldano, Ascierto, Paolo A.
Publicado 2021

Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic Melanoma Patients: Real-World Evide...

por Madonna, Gabriele, Masucci, Giuseppe V., Capone, Mariaelena, Mallardo, Domenico, Grimaldi, Antonio Maria, Simeone, Ester, Vanella, Vito, Festino, Lucia, Palla, Marco, Scarpato, Luigi, Tuffanelli, Marilena, D’angelo, Grazia, Villabona, Lisa, Krakowski, Isabelle, Eriksson, Hanna, Simao, Felipe, Lewensohn, Rolf, Ascierto, Paolo Antonio
Publicado 2021

The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab

por Mallardo, Domenico, Woodford, Rachel, Menzies, Alexander M., Zimmer, Lisa, williamson, Andrew, Ramelyte, Egle, Dimitriou, Florentia, Wicky, Alexandre, Wallace, Roslyn, Mallardo, Mario, Cortellini, Alessio, Budillon, Alfredo, Atkinson, Victoria, Sandhu, Shahneen, Olivier, Michielin, Dummer, Reinhard, Lorigan, Paul, Schadendorf, Dirk, Long, Georgina V., Simeone, Ester, Ascierto, Paolo A.
Publicado 2023

IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab

por Mallardo, Domenico, Simeone, Ester, Festino, Lucia, Tuffanelli, Marilena, Vanella, Vito, Trojaniello, Claudia, Vitale, Maria Grazia, Ottaviano, Margaret, Capone, Mariaelena, Madonna, Gabriele, Sparano, Francesca, Cioli, Eleonora, Scarpato, Luigi, Palla, Marco, Di Trolio, Rossella, Meinardi, Paolo, Caracò, Corrado, Ferrara, Gerardo, Muto, Paolo, Cavalcanti, Ernesta, Ascierto, Paolo Antonio
Publicado 2023

Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization

por Mallardo, Domenico, Simeone, Ester, Vanella, Vito, Vitale, Maria Grazia, Palla, Marco, Scarpato, Luigi, Paone, Miriam, De Cristofaro, Teresa, Borzillo, Valentina, Cortellini, Alessio, Sparano, Francesca, Pignata, Sandro, Fiore, Francesco, Caracò, Corrado, Maiolino, Piera, Petrillo, Antonella, Cavalcanti, Ernesta, Lastoria, Secondo, Muto, Paolo, Budillon, Alfredo, Warren, Sarah, Ascierto, Paolo Antonio
Publicado 2022

Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy

por Montesarchio, Vincenzo, Parrella, Roberto, Iommelli, Chiara, Bianco, Antonella, Manzillo, Elio, Fraganza, Fiorentino, Palumbo, Cristiana, Rea, Gaetano, Murino, Patrizia, De Rosa, Rosanna, Atripaldi, Luigi, D’Abbraccio, Maurizio, Curvietto, Marcello, Mallardo, Domenico, Celentano, Egidio, Grimaldi, Antonio Maria, Palla, Marco, Trojaniello, Claudia, Vitale, Maria Grazia, Million-Weaver, Samuel Lewis, Ascierto, Paolo Antonio
Publicado 2020

Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis

por Isgrò, Maria Antonietta, Vitale, Maria Grazia, Celentano, Egidio, Nocerino, Flavia, Porciello, Giuseppe, Curvietto, Marcello, Mallardo, Domenico, Montagnese, Concetta, Russo, Luigi, Zanaletti, Nicoletta, Avallone, Antonio, Pensabene, Matilde, De Laurentiis, Michelino, Centonze, Sara, Pignata, Sandro, Cannella, Lucia, Morabito, Alessandro, Caponigro, Francesco, Botti, Gerardo, Masucci, Giuseppe Valentino, Giannarelli, Diana, Cavalcanti, Ernesta, Ascierto, Paolo Antonio
Publicado 2021